The score consisting of 3 non-tumorigenic blood factors may provide a universal approach to improve biomarkers in NSCLC patients applying only PD-L1 expression alone and will hopefully serve as useful feedback information for improvements for prediction and prognosis of ICIs in advanced NSCLC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.